The synthetic opioid analog ( d -Ala 2 )Met-enkephalin (DAME) significantly reduces the escape response to a danger stimulus in the crab Chasmagnathus granulatus when administered within the dose range 0.01–1.0 μg/g. There is no reduction with lower or higher doses, thus suggesting a U-shaped dose-response curve. A 0.1-μg/g dose of naloxone has no effect per se on the response, but when it is administered together with DAME, it completely blocks the decrementai effect of this drug and an escape response generally higher than that of control is observed. An explanation for these results in terms of a possible dual action of DAME is offered. In addition, we present evidence for different degrees of opiate sensitivity among crabs of the same population in relation to their different degrees of reactivity to the visual danger stimulus.
Pharmacology Biochemistry and Behavior – Elsevier
Published: Mar 1, 1995
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera